Effect of a switch of aromatase inhibitors to another aromatase inhibitor or tamoxifen on musculoskeletal symptoms in breast cancer; Which is the best?

被引:0
|
作者
Altundag, Kadri [1 ]
机构
[1] MKA Breast Canc Clin, Ankara, Turkey
来源
JOURNAL OF BUON | 2020年 / 25卷 / 04期
关键词
MANAGEMENT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2132 / 2133
页数:2
相关论文
共 50 条
  • [31] Aromatase inhibitors-induced joint pain: Effect of the switch of aromatase inhibitors
    Briot, Karine
    Tubiana, Michele
    Bastit, Laurent
    Kloos, Ioana Muresan
    Roux, Christian
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S686 - S686
  • [32] Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
    Eggemann, Holm
    Altmann, Udo
    Costa, Serban-Dan
    Ignatov, Atanas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (02) : 337 - 341
  • [33] Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors
    Guerrero-Zotano, Angel
    Muggia, Franco
    CURRENT CANCER THERAPY REVIEWS, 2010, 6 (01) : 51 - 61
  • [34] Selection of breast cancer patients for an aromatase inhibitor after radiation and tamoxifen
    Freedman, GM
    Anderson, P
    Li, T
    Ross, E
    Swaby, R
    Goldstein, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S242 - S242
  • [35] Aromatase inhibitors in breast cancer
    Lonning, PE
    ENDOCRINE-RELATED CANCER, 2004, 11 (02) : 179 - 189
  • [36] Aromatase inhibitors in breast cancer
    Brodie, A
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02): : 61 - 65
  • [37] Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak, Catherine H.
    Hayes, Daniel F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (18): : 1261 - 1263
  • [38] Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
    Holm Eggemann
    Udo Altmann
    Serban-Dan Costa
    Atanas Ignatov
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 337 - 341
  • [39] Aromatase inhibitors in breast cancer
    Forrest, ARW
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11): : 1090 - 1090
  • [40] Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study
    Briot, Karine
    Tubiana-Hulin, Michele
    Bastit, Laurent
    Kloos, Ioana
    Roux, Christian
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (01) : 127 - 134